Cancer Trial Shows Zero Relapses After Three Years
A groundbreaking clinical trial using immunotherapy before surgery has shown remarkable results for bowel cancer patients, with no recurrences after 33 months of follow-up. The approach represents a significant shift from traditional treatment methods.